Search SEC
Fundamental Analysis
34 matches · 10756 cached companies
| Company | Fundamental | Momentum | Acceleration | Confidence | Revenue Growth | ROIC | FCF Growth | Op Margin Delta | Share Growth | Dividend Yield | Dividend Years | Payout Ratio | P/E | Signals |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IDXXIDEXX LABORATORIES INC /DE | 74.6 | 65.7 | 79.4 | 91 | +15.99% | +61.74% | n/a | +5.78% | -3.19% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, ROIC expansion, Net debt reduction, Share count reduction, Strong operating leverage |
| ORCLORACLE CORP | 64.1 | 62 | 62 | 92 | +27.49% | +117.11% | -330.45% | +5.65% | +4.38% | 1.41% | 18 | 33.35% | 24.33x | Operating leverage, Net debt reduction, Strong operating leverage3 warnings |
| ORCL-PDORACLE CORP | 64.1 | 62 | 62 | 92 | +27.49% | +117.11% | -330.45% | +5.65% | +4.38% | 5.08% | 1 | 33.35% | 7.6x | Operating leverage, Net debt reduction, Strong operating leverage3 warnings |
| SOPAQSOCIETY PASS INCORPORATED. | 63.7 | 100 | 100 | 86 | -7.19% | -149.62% | n/a | +2,483.79% | +115.98% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, ROIC expansion, Net debt reduction2 warnings |
| DLBDolby Laboratories, Inc. | 49 | 23.5 | 24.6 | 100 | -1.23% | +10.31% | -23.52% | +4.71% | -3.03% | 2.45% | 13 | 60.24% | 24.97x | Net debt reduction, Share count reduction4 warnings |
| CORCencora, Inc. | 47.5 | 50.9 | 30.6 | 100 | +10.05% | +32.24% | -37.57% | +0.08% | -0.59% | 0.78% | 26 | 12.82% | 16.41x | Gross margin expansion, Operating leverage, Share count reduction, Strong operating leverage2 warnings |
| MLABMESA LABORATORIES INC /CO/ | 51.2 | 64.6 | 66.1 | 91 | +5.69% | +7.61% | n/a | +9.16% | +6.04% | 0.48% | 24 | 52.49% | n/a | Gross margin expansion, Operating leverage, ROIC expansion, Net debt reduction, Strong operating leverage |
| AOSA. O. Smith Corporation | 49.3 | 44.7 | 44.7 | 91 | +0.88% | +25.82% | n/a | -1.1% | -4.53% | 2.54% | 41 | 35.83% | 14.84x | Gross margin expansion, Share count reduction |
| VIRCVIRCO MFG CORPORATION | 48.2 | 23.8 | 14.3 | 91 | -5.03% | +12.51% | n/a | +1.48% | -0.23% | 1.54% | 4 | 61.37% | 6.97x | Net debt reduction, Share count reduction4 warnings |
| CANNTREES Corp (Colorado) | 47 | n/a | n/a | 86 | +10.08% | -5.65% | n/a | n/a | -8.36% | 0% | 0 | n/a | n/a | Net debt reduction, Share count reduction1 warning |
| OGENORAGENICS INC | 53.2 | n/a | n/a | 73 | +63.05% | n/a | n/a | n/a | n/a | 0% | 0 | n/a | n/a | Net debt reduction1 warning |
| LOCLLocal Bounti Corporation/DE | 50 | 100 | 78.5 | 75 | +29.79% | -15.33% | n/a | +756.46% | +230.03% | 0% | 0 | n/a | n/a | Operating leverage3 warnings |
| LOCLWLocal Bounti Corporation/DE | 50 | 100 | 78.5 | 75 | +29.79% | -15.33% | n/a | +756.46% | +230.03% | 0% | 0 | n/a | n/a | Operating leverage3 warnings |
| FCXFREEPORT-MCMORAN INC | 40.2 | 66 | 66 | 91 | +10.67% | +28.05% | n/a | -6.26% | -0.07% | 0.83% | 9 | n/a | n/a | Gross margin expansion, Operating leverage, Share count reduction, Strong operating leverage |
| BIOBIO-RAD LABORATORIES, INC. | 37.1 | 51.7 | 52 | 91 | +2.55% | +2.92% | n/a | -7.34% | -4.08% | 0% | 0 | n/a | n/a | Operating leverage, ROIC expansion, Net debt reduction, Share count reduction, Strong operating leverage |
| BIO-BBIO-RAD LABORATORIES, INC. | 37.1 | 51.7 | 52 | 91 | +2.55% | +2.92% | n/a | -7.34% | -4.08% | 0% | 0 | n/a | n/a | Operating leverage, ROIC expansion, Net debt reduction, Share count reduction, Strong operating leverage |
| ABTABBOTT LABORATORIES | 37 | 50.4 | 43.8 | 91 | +9.78% | +8.76% | n/a | -3.33% | -0.03% | 2.54% | 44 | 63.09% | 29.24x | Gross margin expansion, Operating leverage, Share count reduction, Strong operating leverage1 warning |
| BRTXBioRestorative Therapies, Inc. | 47.2 | 0 | 0 | 70 | -6.47% | n/a | n/a | +11,187.34% | +118.28% | 0% | 0 | n/a | n/a | n/a2 warnings |
| ORAORMAT TECHNOLOGIES, INC. | 46.4 | n/a | n/a | 70 | -1.7% | n/a | n/a | n/a | +3.96% | 0.52% | 22 | n/a | n/a | Net debt reduction |
| OSURORASURE TECHNOLOGIES INC | 34.4 | 0 | 8.8 | 89 | -34.45% | -14.83% | n/a | -25.61% | -6.29% | 0% | 0 | n/a | n/a | Net debt reduction, Share count reduction3 warnings |
| GROVGrove Collaborative Holdings, Inc. | 36.7 | 70.3 | 70.3 | 83 | -18.7% | n/a | n/a | +28.66% | +6.13% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, Net debt reduction |
| GROVWGrove Collaborative Holdings, Inc. | 36.7 | 70.3 | 70.3 | 83 | -18.7% | n/a | n/a | +28.66% | +6.13% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, Net debt reduction |
| ORMPORAMED PHARMACEUTICALS INC. | 34.8 | 100 | 100 | 88 | -31.62% | -7.74% | n/a | +224.26% | +5.93% | 5.57% | 1 | n/a | 12.49x | Operating leverage, ROIC expansion, Net debt reduction2 warnings |
| FUNSix Flags Entertainment Corporation/NEW | 38.4 | 0 | 0 | 77 | +50.14% | -16.83% | n/a | n/a | +1.64% | 0% | 0 | n/a | n/a | Gross margin expansion, Net debt reduction1 warning |
| CLBCore Laboratories Inc. /DE/ | 35.6 | 49.1 | 49.1 | 84 | -1.37% | +10.74% | n/a | n/a | +0.22% | 0.4% | 19 | 6.3% | 15.48x | Net debt reduction |
1-25 of 34